Join
Live feed
·
INSIDERFilingvia Quantisnow
Ionis Pharmaceuticals Inc. logo

EVP, Chief Scientific Officer Bennett C Frank was granted 11,421 shares and sold $488,141 worth of shares (5,885 units at $82.95), increasing direct ownership by 6% to 100,293 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IONS (Ionis Pharmaceuticals Inc.) and more on Quantisnow.